Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Trial of Fixed-Dose OPC-34712 (4,2, and 1 mg/day) in the Treatment of Adults with Schizophrenia

Project: Research

Project Details

StatusFinished
Effective start/end date06/1/11 → 12/1/13

Funding

  • Quintiles Incorporated: $14,298.34